R01TW012671
Project Grant
Overview
Grant Description
Adaptation and Feasibility of Many Men Many Voices (3MV), an HIV prevention intervention to reduce intersectional stigma and increase HIVST among YSMM residing in Ghanaian slums - Project Summary
Young sexual minority men (YSMM) make up 63% of the HIV prevalence (18%) among sexual minority men in Ghana, which has a 2% national prevalence rate. Our previous studies that included YSMM in Ghana show that internalized and interpersonal intersectional (HIV, sexual minority, gender expression) stigma and insufficient HIV knowledge impedes HIV testing among SMM.
For those in slums, the social and economic barriers in slum communities can intertwine with intersectional stigma to exacerbate the risk of HIV infections and discourage HIV testing among YSMM. HIV self-testing (HIVST) has the efficacy of increasing testing, providing privacy and convenience. Yet its uptake among YSMM remains daunting due to insufficient expertise and intersectional stigma.
We propose to adapt the Many Men, Many Voices (3MV) to a modified version dubbed LAFIYA (local word meaning wellness) to address intersectional stigma and increase HIVST among YSMM. Whereas 3MV has the efficacy to increase HIV testing among SMM, adaptation for YSMM in slums will show its applicability to young adults and YSMM in a different geographic and socioeconomic context in Ghana and SSA.
LAFIYA will also extend 3MV's utility for HIV prevention by utilizing scientific advancements around intersectional stigma and HIVST options, which came after the original version. Guided by the eight steps of the ADAPT-IT model, we will implement the following aims.
1) Assess intersectional stigma and options for HIVST implementation among YSMM,
2) Adapt 3MV to LAFIYA to address intersectional stigma and HIVST among YSMM, and
3) Test acceptance, feasibility, appropriateness, and preliminary efficacy of LAFIYA to address intersectional stigma and increase HIVST uptake.
In Aim 1, we will conduct in-depth interviews with YSMM (N=20), providers (N=20); clinics=10, and community-based organizations (=10) that work with YSMM to evaluate experiences of intersectional stigma and options for implementing HIV self-testing among YSMM.
In Aim 2, we will conduct a summative analysis to interpret findings from Aim 1 to identify fit and modifications to tailor 3MV to the realities of YSMM in Ghanaian slums.
In Aim 3, we will test the acceptability, feasibility, appropriateness, and preliminary efficacy of LAFIYA through a pilot pre-post intervention among YSMM (N=60). The YSMM will receive the LAFIYA intervention and have the option to pick up HIVST and contact ART providers for support if they test positive. We will assess primary outcomes (acceptability, feasibility, appropriateness) and secondary outcomes (preliminary efficacy) using baseline, immediate, and 3-month post-intervention surveys.
The study will inform the preparation of a clustered randomized control trial to measure LAFIYA's efficacy in increasing HIVST among YSMM. The findings will inform intersectional stigma reduction and HIVST implementation strategies among YSMM, slums, SSA, and other high-risk populations in different settings.
Young sexual minority men (YSMM) make up 63% of the HIV prevalence (18%) among sexual minority men in Ghana, which has a 2% national prevalence rate. Our previous studies that included YSMM in Ghana show that internalized and interpersonal intersectional (HIV, sexual minority, gender expression) stigma and insufficient HIV knowledge impedes HIV testing among SMM.
For those in slums, the social and economic barriers in slum communities can intertwine with intersectional stigma to exacerbate the risk of HIV infections and discourage HIV testing among YSMM. HIV self-testing (HIVST) has the efficacy of increasing testing, providing privacy and convenience. Yet its uptake among YSMM remains daunting due to insufficient expertise and intersectional stigma.
We propose to adapt the Many Men, Many Voices (3MV) to a modified version dubbed LAFIYA (local word meaning wellness) to address intersectional stigma and increase HIVST among YSMM. Whereas 3MV has the efficacy to increase HIV testing among SMM, adaptation for YSMM in slums will show its applicability to young adults and YSMM in a different geographic and socioeconomic context in Ghana and SSA.
LAFIYA will also extend 3MV's utility for HIV prevention by utilizing scientific advancements around intersectional stigma and HIVST options, which came after the original version. Guided by the eight steps of the ADAPT-IT model, we will implement the following aims.
1) Assess intersectional stigma and options for HIVST implementation among YSMM,
2) Adapt 3MV to LAFIYA to address intersectional stigma and HIVST among YSMM, and
3) Test acceptance, feasibility, appropriateness, and preliminary efficacy of LAFIYA to address intersectional stigma and increase HIVST uptake.
In Aim 1, we will conduct in-depth interviews with YSMM (N=20), providers (N=20); clinics=10, and community-based organizations (=10) that work with YSMM to evaluate experiences of intersectional stigma and options for implementing HIV self-testing among YSMM.
In Aim 2, we will conduct a summative analysis to interpret findings from Aim 1 to identify fit and modifications to tailor 3MV to the realities of YSMM in Ghanaian slums.
In Aim 3, we will test the acceptability, feasibility, appropriateness, and preliminary efficacy of LAFIYA through a pilot pre-post intervention among YSMM (N=60). The YSMM will receive the LAFIYA intervention and have the option to pick up HIVST and contact ART providers for support if they test positive. We will assess primary outcomes (acceptability, feasibility, appropriateness) and secondary outcomes (preliminary efficacy) using baseline, immediate, and 3-month post-intervention surveys.
The study will inform the preparation of a clustered randomized control trial to measure LAFIYA's efficacy in increasing HIVST among YSMM. The findings will inform intersectional stigma reduction and HIVST implementation strategies among YSMM, slums, SSA, and other high-risk populations in different settings.
Awardee
Funding Goals
THE JOHN E. FOGARTY INTERNATIONAL CENTER (FIC) SUPPORTS RESEARCH AND RESEARCH TRAINING TO REDUCE DISPARITIES IN GLOBAL HEALTH AND TO FOSTER PARTNERSHIPS BETWEEN U.S. SCIENTISTS AND THEIR COUNTERPARTS ABROAD. FIC SUPPORTS BASIC BIOLOGICAL, BEHAVIORAL, AND SOCIAL SCIENCE RESEARCH, AS WELL AS RELATED RESEARCH TRAINING AND CAREER DEVELOPMENT. THE RESEARCH PORTFOLIO IS DIVIDED INTO SEVERAL PROGRAMS THAT SUPPORT A WIDE VARIETY OF FUNDING MECHANISMS TO MEET PROGRAMMATIC OBJECTIVES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Rochester,
New York
146113847
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Termination This project grant was reported as terminated by the Department of Government Efficiency (DOGE) in March 2025.
Amendment Since initial award the End Date has been shortened from 03/31/26 to 03/21/25 and the total obligations have increased 119% from $216,597 to $474,112.
Amendment Since initial award the End Date has been shortened from 03/31/26 to 03/21/25 and the total obligations have increased 119% from $216,597 to $474,112.
University Of Rochester was awarded
Adapting 3MV to Increase HIVST Among YSMM in Ghanaian Slums
Project Grant R01TW012671
worth $474,112
from Fogarty International Center in July 2023 with work to be completed primarily in Rochester New York United States.
The grant
has a duration of 1 year 8 months and
was awarded through assistance program 93.989 International Research and Research Training.
The Project Grant was awarded through grant opportunity Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional).
Status
(Complete)
Last Modified 4/4/25
Period of Performance
7/15/23
Start Date
3/21/25
End Date
Funding Split
$474.1K
Federal Obligation
$0.0
Non-Federal Obligation
$474.1K
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R01TW012671
Transaction History
Modifications to R01TW012671
Additional Detail
Award ID FAIN
R01TW012671
SAI Number
R01TW012671-2591687432
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NF00 NIH Fogarty International Center
Funding Office
75NF00 NIH Fogarty International Center
Awardee UEI
F27KDXZMF9Y8
Awardee CAGE
03CZ7
Performance District
NY-25
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
John E. Fogarty International Center, National Institutes of Health, Health and Human Services (075-0819) | Health research and training | Grants, subsidies, and contributions (41.0) | $216,597 | 100% |
Modified: 4/4/25